- Home
- OBIO vs ISPR Comparison
OBIO vs ISPR Comparison
Compare OBIO & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ISPR
- Stock Information
- Founded
- OBIO 2017
- ISPR 2019
- Country
- OBIO United States
- ISPR United States
- Employees
- OBIO N/A
- ISPR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- OBIO Health Care
- ISPR Health Care
- Exchange
- OBIO Nasdaq
- ISPR Nasdaq
- Market Cap
- OBIO 147.8M
- ISPR 152.0M
- IPO Year
- OBIO N/A
- ISPR 2023
- Fundamental
- Price
- OBIO $2.75
- ISPR $3.10
- Analyst Decision
- OBIO Strong Buy
- ISPR Strong Buy
- Analyst Count
- OBIO 4
- ISPR 2
- Target Price
- OBIO $14.00
- ISPR $10.00
- AVG Volume (30 Days)
- OBIO 339.4K
- ISPR 51.6K
- Earning Date
- OBIO 08-12-2025
- ISPR 09-19-2025
- Dividend Yield
- OBIO N/A
- ISPR N/A
- EPS Growth
- OBIO N/A
- ISPR N/A
- EPS
- OBIO N/A
- ISPR N/A
- Revenue
- OBIO $2,944,000.00
- ISPR $144,700,345.00
- Revenue This Year
- OBIO $19.83
- ISPR N/A
- Revenue Next Year
- OBIO $12.53
- ISPR $35.39
- P/E Ratio
- OBIO N/A
- ISPR N/A
- Revenue Growth
- OBIO 41.61
- ISPR N/A
- 52 Week Low
- OBIO $2.37
- ISPR $2.09
- 52 Week High
- OBIO $6.50
- ISPR $7.79
- Technical
- Relative Strength Index (RSI)
- OBIO 50.09
- ISPR 56.21
- Support Level
- OBIO $2.65
- ISPR $2.90
- Resistance Level
- OBIO $3.08
- ISPR $3.84
- Average True Range (ATR)
- OBIO 0.16
- ISPR 0.28
- MACD
- OBIO 0.03
- ISPR 0.01
- Stochastic Oscillator
- OBIO 52.86
- ISPR 32.73
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.